Literature DB >> 24838685

Histopathological classification of pauci-immune glomerulonephritis and its impact on outcome.

Godasi S R S N K Naidu1, Aman Sharma, Ritambra Nada, Harbir Singh Kohli, Vivekanand Jha, Krishan Lal Gupta, Vinay Sakhuja, Manish Rathi.   

Abstract

Rapidly progressive renal failure is a common but severe feature of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. A histopathological classification for ANCA-associated pauci-immune glomerulonephritis was developed for prognostication of these patients. The present study aims to classify patients of pauci-immune glomerulonephritis according to this classification and its impact on outcome. Eighty-six subjects with pauci-immune glomerulonephritis between July 2006 and October 2012 were included in the study. Their renal biopsies were reviewed and classified into focal, crescentic, sclerotic and mixed class as per the new classification. The outcomes were analyzed after 6 months of treatment. Of the 86 subjects, 34 (39.53 %) were granulomatosis with polyangiitis, 36 (41.86 %) microscopic polyangiitis, 1 eosinophilic granulomatosis with polyangiitis, while the rest (17.44 %) were unclassifiable. Thirteen (15.5 %), 43 (51.2 %), 12 (14.3 %) and 16 (19 %) patients were classified as focal, crescentic, sclerotic and mixed class, respectively. The mean serum creatinine at baseline was 280.23, 659.46, 573.72 and 542.78 µmol/L in focal, crescentic, sclerotic and mixed class, respectively. The probability of improvement in renal functions at 6 months decreased from focal to crescentic to mixed to sclerotic class, while the probability of death was highest in the sclerotic class followed by the mixed class. This difference in outcome was maintained irrespective of the clinical diagnosis or the Birmingham Vasculitis Activity Score. Our study has shown that the histopathological classification can be used to predict the severity of renal dysfunction as well as the treatment outcomes in pauci-immune glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24838685     DOI: 10.1007/s00296-014-3041-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  35 in total

1.  Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups.

Authors:  Herbert A Hauer; Ingeborg M Bajema; Hans C van Houwelingen; Franco Ferrario; Laure-Hélène Noël; Rüdiger Waldherr; David R W Jayne; Niels Rasmussen; Jan A Bruijn; E Christiaan Hagen
Journal:  Kidney Int       Date:  2002-01       Impact factor: 10.612

2.  Primary systemic vasculitis: clinical features and mortality.

Authors:  S E Lane; R A Watts; L Shepstone; D G I Scott
Journal:  QJM       Date:  2005-01-17

3.  Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: A prospective analysis of 100 patients with severe renal involvement.

Authors:  Robert A F de Lind van Wijngaarden; Herbert A Hauer; Ron Wolterbeek; David R W Jayne; Gill Gaskin; Niels Rasmussen; Laure-Hélène Noël; Franco Ferrario; Rüdiger Waldherr; E Christiaan Hagen; Jan A Bruijn; Ingeborg M Bajema
Journal:  J Am Soc Nephrol       Date:  2006-07-06       Impact factor: 10.121

4.  Clinical and histological outcome predictors in renal limited pauci-immune crescentic glomerulonephritis: a single centre experience.

Authors:  A Gigante; C Salviani; K Giannakakis; E Rosato; B Barbano; A Moroso; M L Gasperini; I Nofroni; F Salsano; R Cianci; F Pugliese
Journal:  Int J Immunopathol Pharmacol       Date:  2012 Jan-Mar       Impact factor: 3.219

5.  Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients.

Authors:  M Gayraud; L Guillevin; P le Toumelin; P Cohen; F Lhote; P Casassus; B Jarrousse
Journal:  Arthritis Rheum       Date:  2001-03

6.  Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.

Authors:  S L Hogan; P H Nachman; A S Wilkman; J C Jennette; R J Falk
Journal:  J Am Soc Nephrol       Date:  1996-01       Impact factor: 10.121

7.  Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity.

Authors:  Alenka Vizjak; Tomaz Rott; Mira Koselj-Kajtna; Blaz Rozman; Stasa Kaplan-Pavlovcic; Dusan Ferluga
Journal:  Am J Kidney Dis       Date:  2003-03       Impact factor: 8.860

Review 8.  Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis.

Authors:  Renato A Sinico; Luca Di Toma; Antonella Radice
Journal:  Autoimmun Rev       Date:  2012-08-16       Impact factor: 9.754

9.  Clinical prognostic factors of renal outcome in anti-neutrophil cytoplasmic autoantibody (ANCA)-associated glomerulonephritis in elderly patients.

Authors:  Stasa Kaplan-Pavlovcic; Kristina Cerk; Radoslav Kveder; Jelka Lindic; Alenka Vizjak
Journal:  Nephrol Dial Transplant       Date:  2003-07       Impact factor: 5.992

10.  Predictors of outcome in idiopathic rapidly progressive glomerulonephritis (IRPGN).

Authors:  Efstathios Alexopoulos; Lazaros Gionanlis; Ekaterini Papayianni; Elizabeth Kokolina; Maria Leontsini; Dimitrios Memmos
Journal:  BMC Nephrol       Date:  2006-11-01       Impact factor: 2.388

View more
  11 in total

1.  Pauci-immune glomerulonephritis in children: a clinicopathologic study of 21 patients.

Authors:  Mazdak A Khalighi; Shihtien Wang; Kammi J Henriksen; Margret Bock; Mahima Keswani; Anthony Chang; Shane M Meehan
Journal:  Pediatr Nephrol       Date:  2015-02-12       Impact factor: 3.714

Review 2.  Histopathologic classification of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis: achievements, limitations, and perspectives.

Authors:  Andrea Hinojosa-Azaola; Ariadna Jiménez-González
Journal:  Clin Rheumatol       Date:  2017-06-14       Impact factor: 2.980

Review 3.  An evaluation of the 2010 histopathological classification of anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis: a Bayesian network meta-analysis.

Authors:  Shanshan Huang; Qing Shen; Ruoqing Yang; Heng Lai; Jing Zhang
Journal:  Int Urol Nephrol       Date:  2018-07-25       Impact factor: 2.370

Review 4.  Developments in the Histopathological Classification of ANCA-Associated Glomerulonephritis.

Authors:  Emma E van Daalen; Maria A C Wester Trejo; Arda Göçeroğlu; Franco Ferrario; Kensuke Joh; Laure-Hélène Noël; Yayoi Ogawa; Suzanne Wilhelmus; Miriam J Ball; Eva Honsova; Zdenka Hruskova; Renate Kain; Tomoyoshi Kimura; Marek Kollar; Andreas Kronbichler; Kristine Lindhard; Xavier Puéchal; Steven Salvatore; Wladimir Szpirt; Hideki Takizawa; Vladimir Tesar; Annelies E Berden; Olaf M Dekkers; E Christiaan Hagen; Jan Oosting; Chinar Rahmattulla; Ron Wolterbeek; Willem Jan Bos; Jan A Bruijn; Ingeborg M Bajema
Journal:  Clin J Am Soc Nephrol       Date:  2020-07-28       Impact factor: 8.237

5.  Serum creatinine level and ESR values associated to clinical pathology types and prognosis of patients with renal injury caused by ANCA-associated vasculitis.

Authors:  Hongda Liang; Miaomiao Xin; Lei Zhao; Liqin Wang; Mingshu Sun; Jibo Wang
Journal:  Exp Ther Med       Date:  2017-10-16       Impact factor: 2.447

6.  Methimazole-Induced Pauci-Immune Glomerulonephritis and Anti-Phospholipid Syndrome: An Important Association to Be Aware of.

Authors:  Huzaif Qaisar; Mohammad A Hossain; Monika Akula; Jennifer Cheng; Mayurkumar Patel; Zheng Min; Halyna Kuzyshyn; Michael Levitt; Shana M Coley; Arif Asif
Journal:  J Clin Med Res       Date:  2018-09-10

7.  Prognostic Factors in Anti-Neutrophil Cytoplasmic Antibody-Associated Glomerulonephritis with Severe Glomerular Sclerosis: A National Registry-Based Cohort Study.

Authors:  Rune Bjørneklett; Vilde Solbakken; Leif Bostad; Anne-Siri Fismen
Journal:  Patholog Res Int       Date:  2018-06-03

8.  Pathological severity determines the renal recovery for anti-myeloperoxidase antibody-associated vasculitis requiring dialysis at disease onset: a retrospective study.

Authors:  Peng-Cheng Xu; Tong Chen; Si-Jing Wu; Xia Yang; Shan Gao; Shui-Yi Hu; Li Wei; Tie-Kun Yan
Journal:  BMC Nephrol       Date:  2019-07-30       Impact factor: 2.388

9.  Histopathological Classification-A Prognostic Tool for Rapidly Progressive Glomerulonephritis.

Authors:  Marta Kantauskaitė; Agnė Laučytė-Cibulskienė; Marius Miglinas
Journal:  Medicina (Kaunas)       Date:  2018-04-17       Impact factor: 2.430

10.  Prognosis and Histological Classification in Elderly Patients with ANCA-Glomerulonephritis: A Registry-Based Cohort Study.

Authors:  Rune Bjørneklett; Leif Bostad; Anne-Siri Fismen
Journal:  Biomed Res Int       Date:  2018-05-31       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.